Metabolic syndrome contributes to cognitive impairment in patients with Parkinson's disease
Ziyi Peng(Army Medical University), Huadong Zhou(Army Medical University), Yan‐Jiang Wang(Army Medical University), Yong Tao(University of Electronic Science and Technology of China), Yang Chen(University of Southern California), Hongdang Qu(First Affiliated Hospital of Bengbu Medical College), Yingchao Huo(Army Medical University), Zhi‐Qiang Xu(Nanjing Medical University), Wen Huang(Army Medical University), Shuyang Dong(Anhui University of Science and Technology), Juan Liu(Nanjing Drum Tower Hospital), Zhenhua Zhou(Army Medical University)
Cited by 28
Related Papers
Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model
|Acta Neuropathologica|2017|125
Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model
|International Journal of Molecular Medicine|2015|104